Résultats du concours de janvier 2019 pour les subventions pour l’innovation
Nous avons le plaisir d’annoncer les résultats du plus récent concours de bourses pour l'innovation. Ce concours vise à appuyer des initiatives de recherche uniques et créatives contre le cancer. Voici une liste des bourses pour l’innovation qui ont été accordées récemment par la Société canadienne du cancer.
Sur un total de 176 demandes, 32 Subventions pour l’innovation de la SCC ont été approuvées, ce qui représente un taux de succès de 18 %. C’est grâce aux efforts substantiels déployés par les donateurs et les bénévoles de la SCC partout au pays et grâce à nos partenaires de financement que nous avons pu injecter ces fonds à l’occasion du présent concours. La Fondation Lotte and John Hecht a financé 1 Subvention pour l'innovation. Ces projets totalisent un investissement de près de 6,4 millions de dollars pour toute la durée des subventions.
Résumés scientifique des Subventions pour l'innovation (en anglais seulement)
Statistiques du programme (en anglais seulement)
Remarques :
- Les sommes indiquées ci-dessus représentent le montant total en dollars accordé par année de subvention et peuvent comprendre des fonds réservés aux salaires, aux fournitures et à l’équipement.
- La date de début de ces bourses est le 1er août 2019.
- Seul le nom du chercheur principal apparaît dans la liste. Le chercheur principal associé, les codemandeurs et les auteurs supplémentaires peuvent être associés à ces bourses.
Note importante :
Bien que nous ayons pris toutes les précautions pour assurer l'exactitude de la liste présentée ci-dessus, celle-ci n'a pas valeur d'avis officiel.
Les gagnants du concours de bourses recevront une notification écrite officielle de bourse dans laquelle figureront les détails relatifs à celle-ci.
Candidat
Établissement
Titre
Établissement
Titre
Subvention
Audet Walsh, Etienne
Laval University
Inhibition of the AMPK metabolic program for the treatment of prostate cancer
Laval University
Inhibition of the AMPK metabolic program for the treatment of prostate cancer
2019/2020 : $40,500
2020/2021 : $100,000
2021/2022 : $59,500
2020/2021 : $100,000
2021/2022 : $59,500
Brockman, Mark
Simon Fraser University
Toward improved immunotherapy for ovarian cancer: quantifying the diversity, phenotype and temporal dynamics of tumour reactive T cells from primary treatment to relapse
Simon Fraser University
Toward improved immunotherapy for ovarian cancer: quantifying the diversity, phenotype and temporal dynamics of tumour reactive T cells from primary treatment to relapse
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Brooks, David
Princess Margaret Cancer Centre UHN
Visualizing interferon signatures to predict efficacy of cancer immunotherapy
Princess Margaret Cancer Centre UHN
Visualizing interferon signatures to predict efficacy of cancer immunotherapy
2019/2020 : $99,840
2020/2021 : $99,980
2020/2021 : $99,980
Brotto, Lori
University of British Columbia
Mindfulness based treatment for sexual difficulties following breast cancer
University of British Columbia
Mindfulness based treatment for sexual difficulties following breast cancer
2019/2020 : $68,533
2020/2021 : $66,533
2021/2022 : $64,903
2020/2021 : $66,533
2021/2022 : $64,903
Brown, Grant
University of Toronto
Targeting cytosine deaminases in pancreatic cancer cells.
University of Toronto
Targeting cytosine deaminases in pancreatic cancer cells.
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Cunningham, John
Centre for Addiction and Mental Health
Offering nicotine patches to all households in a municipality with high smoking rates: Test of an innovative idea to promote large increases in tobacco cessation
Centre for Addiction and Mental Health
Offering nicotine patches to all households in a municipality with high smoking rates: Test of an innovative idea to promote large increases in tobacco cessation
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Downar, James
Bruyère Research Institute
Transcranial magnetic stimulation for psychological distress in patients with advanced cancer
*funded by the Lotte & John Hecht Memorial Foundation
Bruyère Research Institute
Transcranial magnetic stimulation for psychological distress in patients with advanced cancer
*funded by the Lotte & John Hecht Memorial Foundation
2019/2020 : $87,206
2020/2021 : $100,000
2020/2021 : $100,000
Foulkes, William
The Research Institute of the McGill University Health Centre (RI MUHC)
Using mutational signatures and functional genomics to classify breast cancer gene variants
The Research Institute of the McGill University Health Centre (RI MUHC)
Using mutational signatures and functional genomics to classify breast cancer gene variants
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Fu, YangXin
University of Alberta
Role of RNA methyltransferase NSUN5 in glioblastoma
University of Alberta
Role of RNA methyltransferase NSUN5 in glioblastoma
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Ghert, Michelle
McMaster University
The Surveillance AFter Extremity Tumour surgerY (SAFETY) international pilot randomized controlled trial
McMaster University
The Surveillance AFter Extremity Tumour surgerY (SAFETY) international pilot randomized controlled trial
2019/2020 : $55,249
2020/2021 : $76,191
2021/2022 : $68,560
2020/2021 : $76,191
2021/2022 : $68,560
Haeryfar, S.M. Mansour
Western University
MAIT cell functions and therapeutic potentials in metastatic colorectal carcinoma
Western University
MAIT cell functions and therapeutic potentials in metastatic colorectal carcinoma
2019/2020 : $99,932
2020/2021 : $100,000
2020/2021 : $100,000
Hope, Kristin
McMaster University
Identification of novel factors mediating oncogenic splice events
McMaster University
Identification of novel factors mediating oncogenic splice events
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Houry, Walid
University of Toronto
Dysregulation of mitochondrial protein homeostasis for cancer treatment
University of Toronto
Dysregulation of mitochondrial protein homeostasis for cancer treatment
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Kafri, Ran
The Hospital for Sick Children
Pharmacologic prevention of malignancy in li fraumeni syndrome
The Hospital for Sick Children
Pharmacologic prevention of malignancy in li fraumeni syndrome
2019/2020 : $99,510
2020/2021 : $99,510
2020/2021 : $99,510
Khokha, Rama
Princess Margaret Cancer Centre UHN
Harnessing therapeutic targets in pancreatic cancer stroma
Princess Margaret Cancer Centre UHN
Harnessing therapeutic targets in pancreatic cancer stroma
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Li, Shyh Dar
University of British Columbia
A drug delivery technology for activating the tumor immune microenvironment of peritoneal metastases
University of British Columbia
A drug delivery technology for activating the tumor immune microenvironment of peritoneal metastases
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Li, Yingfu
McMaster University
Investigating novel biomarkers of pancreatic cancer
McMaster University
Investigating novel biomarkers of pancreatic cancer
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Liu, Geoffrey
Princess Margaret Cancer Centre UHN
Breathomics as a non invasive, inexpensive, point of care predictive test for immune checkpoint inhibitor efficacy
Princess Margaret Cancer Centre UHN
Breathomics as a non invasive, inexpensive, point of care predictive test for immune checkpoint inhibitor efficacy
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Lorimer, Ian
Ottawa Hospital Research Institute
Tumour suppressor therapy for glioblastoma
Ottawa Hospital Research Institute
Tumour suppressor therapy for glioblastoma
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Lupien, Mathieu
Princess Margaret Cancer Centre UHN
Pancancer analysis to discover the epigenetic determinants of tumour initiating cells (TICs).
Princess Margaret Cancer Centre UHN
Pancancer analysis to discover the epigenetic determinants of tumour initiating cells (TICs).
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Muller, William
McGill University
Evaluating the role of integrin signalling in breast cancer dormancy
McGill University
Evaluating the role of integrin signalling in breast cancer dormancy
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Nepveu, Alain
McGill University
DNA repair properties and vulnerability of triple negative breast cancer cells
McGill University
DNA repair properties and vulnerability of triple negative breast cancer cells
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Penn, Linda
Princess Margaret Cancer Centre UHN
Exploiting an actionable metabolic vulnerability in high risk myeloma
Princess Margaret Cancer Centre UHN
Exploiting an actionable metabolic vulnerability in high risk myeloma
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Raouf, Afshin
CancerCare Manitoba
Identification and characterization of clonogenic cells in primary ER+ human breast cancer tumors
CancerCare Manitoba
Identification and characterization of clonogenic cells in primary ER+ human breast cancer tumors
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Razak, Fahad
St. Michael's Hospital
ONCO GEMINI: ONcology Continuum GEneral Medicine INpatient Initiative; comparing cancer patients admitted to oncology vs non oncology services
St. Michael's Hospital
ONCO GEMINI: ONcology Continuum GEneral Medicine INpatient Initiative; comparing cancer patients admitted to oncology vs non oncology services
2019/2020 : $99,127
2020/2021 : $99,792
2020/2021 : $99,792
Schaeffer, David
University of British Columbia
Targeting metabolic plasticity in pancreatic cancer
University of British Columbia
Targeting metabolic plasticity in pancreatic cancer
2019/2020 : $99,563
2020/2021 : $99,563
2020/2021 : $99,563
Schimmer, Aaron
Princess Margaret Cancer Centre UHN
Targeting the mitochondrial protease, NLN, in acute myeloid leukemia
Princess Margaret Cancer Centre UHN
Targeting the mitochondrial protease, NLN, in acute myeloid leukemia
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Schramek, Daniel
Mount Sinai Hospital
Mapping the determinants of effective immunotherapy using multiplexed, direct in vivo CRISPR screens
Mount Sinai Hospital
Mapping the determinants of effective immunotherapy using multiplexed, direct in vivo CRISPR screens
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Sylvestre, Marie Pierre
Centre de recherche du CHUM
A prognostic tool for regular cannabis use among youth: A precursor to lowering cannabis related cancer risk
Centre de recherche du CHUM
A prognostic tool for regular cannabis use among youth: A precursor to lowering cannabis related cancer risk
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Yasufuku, Kazuhiro
The Toronto Hospital (General Division) UHN
Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome based dual modality nanoparticle
The Toronto Hospital (General Division) UHN
Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome based dual modality nanoparticle
2019/2020 : $99,868
2020/2021 : $99,560
2020/2021 : $99,560
Zemp, Roger
University of Alberta
Amplification and Enrichment Platforms for Liquid Biopsy based Early Prognostication of Cancer
University of Alberta
Amplification and Enrichment Platforms for Liquid Biopsy based Early Prognostication of Cancer
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Zhang, Wei
University of Guelph
Engineering HPV oncoprotein E6 for inhibitors of cancer progression
University of Guelph
Engineering HPV oncoprotein E6 for inhibitors of cancer progression
2019/2020 : $100,000
2020/2021 : $100,000
2020/2021 : $100,000
Dernière modification le: 15 juillet 2019